Hólyagrák: vizsgálatok itt: Ausztrália
33 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
- Where
- Macquarie, South Brisbane
- Életkor
- 18 év and over
- People
- 590 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07419295 · EU 2024-520014-22-00 - 1. fázisTaking peopleFORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- Where
- Darlinghurst, Hunter Region, NSW, St Leonards, Sydney
- Életkor
- 18 év and over
- People
- 677 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05614739 · EU 2022-502755-59-00 - 1. fázisTaking peopleA Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Where
- Darlinghurst, Nedlands
- Életkor
- 18 év and over
- People
- 460 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06465069 · EU 2024-512927-36-00 - 2. fázisTaking peopleA Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Where
- Blacktown, Southport, Sydney
- Életkor
- 18 év and over
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00 - 1. fázisTaking peopleStudy of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors
- Where
- Darlinghurst
- Életkor
- 18 év and over
- People
- 156 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07660055 - 2. fázisTaking peopleA Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder
- Where
- New South Wales, Southport
- Életkor
- 18 év and over
- People
- 240 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT07475806 - 1. fázisTaking peopleA Study of MGC026 in Participants With Advanced Solid Tumors
- Where
- Auchenflower, Heidelberg, Kurralta Park
- Életkor
- 18 év and over
- People
- 394 worldwide
- Run by
- MacroGenics
See details and how to joinNCT06242470 - 2. fázisTaking peopleEfficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
- Where
- Richmond
- Életkor
- 18 év and over
- People
- 90 worldwide
- Run by
- Tyra Biosciences, Inc
See details and how to joinNCT06995677 · EU 2025-521277-14-00 - 2. fázisTaking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Camperdown, Chermside, Clayton, Hobart, Hyde Park
- Életkor
- 18 év and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - 1/2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Blacktown, Mount Kuring-Gai, St Leonards, Subiaco, Woolloongabba
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - 1/2. fázisTaking peopleA Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
- Where
- Clayton, Heidelberg
- Életkor
- 18 év and over
- People
- 245 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT07186842 · EU 2025-522613-26-00 - Korai 1. fázisTaking peopleImaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC
- Where
- Nedlands, Perth, St Leonards
- Életkor
- 18 év and over
- People
- 40 worldwide
- Run by
- RayzeBio, Inc.
See details and how to joinNCT07671092 - 2. fázisTaking peoplePerioperative Durvalumab With Neoadjuvant ddMVAC in Patients With Muscle-Invasive Bladder Cancer (NIAGARA-2)
- Where
- Chermside, Elizabeth Vale, Heidelberg, Hong Kong, Kogarah, Macquarie University, Murdoch, Port Macquarie, St Leonards
- Életkor
- 18 év and over
- People
- 150 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06960577 · EU 2024-519246-75-01 - 1/2. fázisTaking peopleSymbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
- Where
- Auchenflower, Clayton, North Ryde
- Életkor
- 18 év and over
- People
- 132 worldwide
- Run by
- Pfizer
See details and how to joinNCT07421700 · EU 2025-523523-21-00 - 3. fázisTaking peopleA Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Where
- Box Hill, Brisbane, Campbelltown, Heidelberg, Macquarie University, Perth, Randwick, St Albans, Waratah
- Életkor
- 18 év and over
- People
- 450 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07218380 · EU 2025-522855-25-00 - 1. fázisTaking peopleStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Albury, Birtinya, Brisbane, Saint Leonards, Sydney
- Életkor
- 18 év and over
- People
- 1394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00 - 2. fázisTaking peopleA Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- Where
- Macquarie University, Perth
- Életkor
- 18 év and over
- People
- 308 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06833073 · EU 2024-517335-46-00 - 1/2. fázisTaking peopleStudy of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- Where
- Bedford Park, Clayton, Frankston, Heidelberg, Melbourne, Miranda, Saint Albans
- Életkor
- 18 év and over
- People
- 159 worldwide
- Run by
- Aulos Bioscience, Inc.
See details and how to joinNCT05267626 - 1/2. fázisTaking peopleSL-28 for Advanced Solid Tumours
- Where
- Adelaide, Gold Coast, Sydney
- Életkor
- 18 év and over
- People
- 60
- Run by
- Second Life Therapeutics
See details and how to joinNCT07341737 - 1. fázisTaking peopleA First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors
- Where
- Southport, Waratah
- Életkor
- 18 év to 75 év
- People
- 299 worldwide
- Run by
- Huahui Health
See details and how to joinNCT07623369 - 1/2. fázisTaking peopleA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Blacktown, Brisbane, Liverpool, Malvern, Melbourne, Nedlands
- Életkor
- 18 év and over
- People
- 1109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709 - 1/2. fázisTaking peopleA Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
- Where
- Melbourne, Sydney
- Életkor
- 18 év and over
- People
- 270 worldwide
- Run by
- Lumara Bio Oncologics GmbH
See details and how to joinNCT05706129 · EU 2023-504254-35-00 - 1/2. fázisTaking peopleLEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Where
- Southport, Wahroonga, Windsor Gardens
- Életkor
- 18 év and over
- People
- 350 worldwide
- Run by
- enGene, Inc.
See details and how to joinNCT04752722 · EU 2024-512900-20-00 - 1. fázisTaking peopleIDOV-Immune for Advanced Solid Tumors
- Where
- Melbourne, Westmead
- Életkor
- 18 év and over
- People
- 78 worldwide
- Run by
- ViroMissile, Inc.
See details and how to joinNCT06910657 - 2/3. fázisTaking peoplePhase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
- Where
- Heidelberg, Macquarie University, St Leonards
- Életkor
- 18 év and over
- People
- 470 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07106762